These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36690646)

  • 1. Phosphorylation of UHRF2 affects malignant phenotypes of HCC and HBV replication by blocking DHX9 ubiquitylation.
    Wu K; Zhang Y; Liu Y; Li Q; Chen Y; Chen J; Duan C
    Cell Death Discov; 2023 Jan; 9(1):27. PubMed ID: 36690646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.
    Cheng F; Qian G; Fang X; Sun J; Chen S; Chen R; Liu S; Li Z; Wu K; Jiang S; Chen Y; Tang N; Chen J; Duan C
    Hepatol Int; 2021 Jun; 15(3):707-719. PubMed ID: 33876395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells.
    Zhang T; Zhao L; Zeng S; Bai L; Chen J; Zhang Z; Wang Y; Duan C
    Int J Mol Med; 2017 Jan; 39(1):126-134. PubMed ID: 28004105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEDD4 Induces K48-Linked Degradative Ubiquitination of Hepatitis B Virus X Protein and Inhibits HBV-Associated HCC Progression.
    Wan T; Lei Z; Tu B; Wang T; Wang J; Huang F
    Front Oncol; 2021; 11():625169. PubMed ID: 33767993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma.
    Shi T; Hua Q; Ma Z; Lv Q
    Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circSFMBT2 downregulation by HBx promotes hepatocellular carcinoma metastasis via the miR-665/TIMP3 axis.
    Liu H; Yan Y; Lin J; He C; Liao H; Li H; Zhou Z; Wang J; Mao K; Xiao Z
    Mol Ther Nucleic Acids; 2022 Sep; 29():788-802. PubMed ID: 36159591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
    BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UHRF2 promotes the malignancy of hepatocellular carcinoma by PARP1 mediated autophagy.
    Zhang Y; Wu K; Liu Y; Sun S; Shao Y; Li Q; Sui X; Duan C
    Cell Signal; 2023 Sep; 109():110782. PubMed ID: 37356603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBx mediated Increase of SIRT1 Contributes to HBV-related Hepatocellular Carcinoma Tumorigenesis.
    Wang Q; Cheng ST; Chen J
    Int J Med Sci; 2020; 17(12):1783-1794. PubMed ID: 32714081
    [No Abstract]   [Full Text] [Related]  

  • 11. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CUL4B facilitates HBV replication by promoting HBx stabilization.
    Shan H; Wang B; Zhang X; Song H; Li X; Zou Y; Jiang B; Hu H; Dou H; Shao C; Gao L; Ma C; Yang X; Liang X; Gong Y
    Cancer Biol Med; 2021 May; 19(1):120-31. PubMed ID: 33969670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular antibody targeting HBx suppresses invasion and metastasis in hepatitis B virus-related hepatocarcinogenesis via protein phosphatase 2A-B56γ-mediated dephosphorylation of protein kinase B.
    Che L; Du ZB; Wang WH; Wu JS; Han T; Chen YY; Han PY; Lei Z; Chen XX; He Y; Xu L; Lin X; Lin ZN; Lin YC
    Cell Prolif; 2022 Nov; 55(11):e13304. PubMed ID: 35811356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
    Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
    Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN/AKT/NF-κB axis.
    Liu Y; Wang J; Chen J; Wu S; Zeng X; Xiong Q; Guo Y; Sun J; Song F; Xu J; Yuan S; Li C; He Y; Wang M; Chen L; Shi YB; Guo M; Guo D; Sun G
    Mol Ther Nucleic Acids; 2022 Sep; 29():47-63. PubMed ID: 35795482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
    Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
    Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.
    Wu Q; Zhang L; Xu X; Zhang Y; Shi J; Lin X; Chen W
    J Virol; 2022 Jul; 96(13):e0061122. PubMed ID: 35695579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UHRF2, another E3 ubiquitin ligase for p53.
    Bai L; Wang X; Jin F; Yang Y; Qian G; Duan C
    Biochem Biophys Res Commun; 2012 Sep; 425(4):908-11. PubMed ID: 22902639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.
    Oh Y; Chung KC
    J Biol Chem; 2013 Mar; 288(13):9102-11. PubMed ID: 23404503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.